Prognostic factors in malignant ovarian germ cell tumours (The Surveillance, Epidemiology and End Results experience 1978-2010)

European Journal of Cancer

Volumn 50, Issue 11, 2014, Pages 1942-1950

  Solheim, O ^a   Gershenson, D M ^b   Trope C G ^a,c   Rokkones, E ^a   Sun, C C ^b   Weedon Fekjaer, H ^d   Fossa S D ^a,c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

Cisplatin; Malignant ovarian germ cell tumours; Survival

Indexed keywords

ADULT; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; DISTANT METASTASIS; DYSGERMINOMA; FEMALE; GERM CELL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; SECOND CANCER; SOCIAL STATUS; SURVIVAL TIME;

CISPLATIN; MALIGNANT OVARIAN GERM CELL TUMOURS; SURVIVAL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; PROGNOSIS; SEER PROGRAM; SOCIOECONOMIC FACTORS; SURVIVAL ANALYSIS; UNITED STATES; YOUNG ADULT;

EID: 84902282356     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2014.03.288     Document Type: Article

References (24)

1. H.O. Smith, M. Berwick, and C.F. Verschraegen et al. Incidence and survival rates for female malignant germ cell tumors Obstet Gynecol 107 2006 1075 1085
2. R.S. Arora, R.D. Alston, and T.O. Eden et al. Comparative incidence patterns and trends of gonadal and extragonadal germ cell tumors in England, 1979-2003 Cancer 118 2012 4290 4297
3. N. Murugaesu, P. Schmid, and G. Dancey et al. Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment Jpn J Clin Oncol 24 2006 4862 4866
4. D.M. Gershenson Management of ovarian germ cell tumors Jpn J Clin Oncol 25 2007 2938 2943
5. J.N. Poynter, J.F. Amatruda, and J.A. Ross Trends in incidence and survival of pediatric and adolescent patients with germ cell tumors in the United States, 1975-2006 Cancer 116 2010 4882 4891
6. C.S. Bryant, S. Kumar, and J.P. Shah et al. Racial disparities in survival among patients with germ cell tumors of the ovary - United States Gynecol Oncol 114 3 2009 437 441
7. J.K. Chan, K.S. Tewari, and S. Waller et al. The influence of conservative surgical practices for malignant ovarian germ cell tumors J Surg Oncol 98 2 2008 111 116
8. A. Stang, B. Trabert, and N. Wentzensen et al. Gonadal and extragonadal germ cell tumours in the United States, 1973-2007 Int J Androl 35 2012 616 625
9. S.D. Fosså, M. Cvancarova, and L. Chen et al. Adverse prognostic factors for testicular cancer-specific survival: a population-based study of 27,948 patients Jpn J Clin Oncol 129 8 2011 963 970
10. Judd W. Moul, Richard K. Dodge, and Judith E. Robertson et al. The impact of the "cisplatin era" of treatment on survival in testicular cancer World J Urol 9 1991 45 50
11. O. Solheim, J. Kærn, and C.G. Tropé et al. Malignant ovarian germ cell tumors: Presentation, survival and second cancer in a population based Norwegian cohort (1953-2009) Gynecol Oncol 131 11 2013 330 335
12. L.H. Einhorn, and J. Donohue Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. 1997 J Urol 167 2002 928 932
13. P. Boyle Testicular cancer: the challenge for cancer control Lancet Oncol 5 1 2004 Jan 56 61
14. T. Matsuda, and H. Yako-Suketomo Comparison of time trends in testis cancer mortality (1990-2006) between countries based on the WHO mortality database Jpn J Clin Oncol 10 2010 996 997
15. Surveillance, Epidemiology, and End Results (SEER) Program. Database: Incidence - SEER 18 Regs Research Data + Hurrican Katrina Impacted Louisiana Cases, Nov 2011 Sub (1973-2009 varying) - Linked to County Attributes - Total U.S., 1969-2010 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2012, base on the November 2011 submission.
16. M.C. Gainford, A. Tinker, and J. Carter et al. Malignant transformation within ovarian dermoid cysts: an audit of treatment received and patient outcomes. An Australia New Zealand gynaecological oncology group (ANZGOG) and gynaecologic cancer intergroup (GCIG) study Int J Gynecol Cancer 20 1 2010 Jan 75 81 10.1111/IGC.0b013e3181c7fccf
17. F. Kikkawa, H. Ishikawa, and K. Tamakoshi et al. Squamous cell carcinoma arising from mature cystic teratoma of the ovary: a clinicopathologic analysis Obstet Gynecol 89 6 1997 1017 1022
18. E.J. Feuer, C.M. Frey, and O.W. Brawley et al. After a treatment breakthrough: a comparison of trial and population-based data for advanced testicular cancer Jpn J Clin Oncol 12 1994 368 377
19. E.J. Feuer, L.G. Kessler, and S.G. Baker et al. The impact of breakthrough clinical trials on survival in population based tumor registries J Clin Epidimiol 44 1991 141 153
20. W.J. Mackillop, J. Zhang-Salomons, and P.A. Groome et al. Socioeconomic status and cancer survival in Ontario Jpn J Clin Oncol 15 1997 1680 1689
21. A.A. Ayal, M.H. Chen, and P.M. Ellen et al. Marital status and survival in patients with cancer Jpn J Clin Oncol 31 2013 3869 3876
22. A. Quaglia, R. Lillini, and C. Mamo et al. Socio-economic inequalities: a review of methodological issues and the relationships with cancer survival Crit Rev Oncol Hematol 85 2013 266 277
23. M. Osswald, L.C. Harlan, and D. Penson et al. Treatment of a population based sample of men diagnosed with testicular cancer in the United States Urol Oncol 6 2008 604 610
24. L.B. Travis, S.D. Fosså, and S.J. Schonfeld et al. Second cancer among 40,576 testicular cancer patients: focus on long-term survivors J Natl Cancer 97 2005 1354 1365